New developments in the pharmacological management of prostate cancer.
Fitzpatrick
J M
JM
Department of Surgery, Mater Misericordiae Hospital, University College Dublin, Ireland. profsurg@iol.ie
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects; D065128:Endothelin Receptor Antagonists; D015316:Genetic Therapy / Q000379:methods; D007987:Gonadotropin-Releasing Hormone / Q000037:antagonists & inhibitors; D006801:Humans; D008190:Lyases / Q000037:antagonists & inhibitors; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D018931:Antineoplastic Agents, Hormonal; D065128:Endothelin Receptor Antagonists; D007987:Gonadotropin-Releasing Hormone; D008190:Lyases